![Xiu Feng Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiu Feng Li
Direttore/Membro del Consiglio presso CHANGCHUN BCHT BIOTECHNOLOGY CO.
Patrimonio netto: 226 794 $ in data 31/05/2024
Profilo
Xiu Feng Li è vice direttore generale di Changchun High & New Technology Industries (Group), Inc. e fa parte del consiglio di amministrazione di altre 8 società. Il signor Li si è laureato all'Università di Jilin.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
21/04/2023 | 15 675 ( 0.58% ) | 226 794 $ | 31/05/2024 |
Posizioni attive di Xiu Feng Li
Società | Posizione | Inizio |
---|---|---|
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Corporate Officer/Principal | 26/06/2018 |
CHANGCHUN BCHT BIOTECHNOLOGY CO. | Direttore/Membro del Consiglio | 01/03/2004 |
Changchun BCHT Pharmaceuticals Co. Ltd. | Direttore/Membro del Consiglio | 20/08/2010 |
Changchun Chenguang Pharmaceutical Co. Ltd. | Direttore/Membro del Consiglio | 20/08/2010 |
Jilin Maifeng Biological Pharmaceutical Co., Ltd. | Direttore/Membro del Consiglio | 20/08/2010 |
Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | Direttore/Membro del Consiglio | 20/08/2010 |
Jilin Huakang Pharmaceutical Co. Ltd.
![]() Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Dunhua, China. | Direttore/Membro del Consiglio | 12/03/2014 |
GeneScience Pharmaceuticals Co., Ltd.
![]() GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Direttore/Membro del Consiglio | 18/03/2014 |
Changchun Baiyi Pharmaceutical Co., Ltd.
![]() Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Direttore/Membro del Consiglio | 01/08/2013 |
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Xiu Feng Li
Jilin University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Health Technology |
CHANGCHUN BCHT BIOTECHNOLOGY CO. | Health Technology |
Aziende private | 8 |
---|---|
Changchun BCHT Pharmaceuticals Co. Ltd. | |
Changchun Chenguang Pharmaceutical Co. Ltd. | |
Jilin Maifeng Biological Pharmaceutical Co., Ltd. | |
Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | |
Jilin Huakang Pharmaceutical Co. Ltd.
![]() Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Dunhua, China. | Health Technology |
GeneScience Pharmaceuticals Co., Ltd.
![]() GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Health Technology |
Changchun Baiyi Pharmaceutical Co., Ltd.
![]() Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Health Technology |
Changchun Genescience Pharmaceuticals Co., Ltd.
![]() Changchun Genescience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Genescience Pharmaceuticals Co., Ltd. is a company that manufactures pharmaceutical products. Changchun Genescience Pharmaceuticals Co., Ltd. is based in Changchun, China. The Chinese company was founded in 1997. The CEO is Lei Jin. | Health Technology |
- Borsa valori
- Insiders
- Xiu Feng Li